William John Scheessele, Chief Commercial Officer at Humacyte, Inc. (HUMA), bought 10,525 shares at $4.72 ($50K) on 2022-05-24, disclosed to the SEC on 2022-05-25.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |